Improved Biopharmaceutical Performance of Coenzyme Q10 Through Solid Lipid Nanoparticles for Enhanced Brain Delivery

Improved Biopharmaceutical Performance of Coenzyme Q10 Through Solid Lipid Nanoparticles for Enhanced Brain Delivery

Coenzyme Q10 (CoQ) is a powerful antioxidant with neuroprotective characteristics; nevertheless, its clinical use is constrained by inadequate solubility, diminished bioavailability, and limited blood–brain barrier (BBB) penetration. Solid lipid nanoparticles (SLNs) offer a promising approach to imp...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shimul Halder, Faria Nasrin, Manik Chandra Shill, Madhabi Lata Shuma, Md. Zakir Sultan, Md. Selim Reza
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	Scientifica
Online Access:	http://dx.doi.org/10.1155/sci5/9034181
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Self-micellizing solid dispersion of thymoquinone with enhanced biopharmaceutical and nephroprotective effects
by: Shimul Halder, et al.
Published: (2024-12-01)

Gynura procumbens leaf extract-loaded self-microemulsifying drug delivery system offers enhanced protective effects in the hepatorenal organs of the experimental rats.
by: Manik Chandra Shill, et al.
Published: (2025-01-01)

Effects of coenzyme q10 on lipid profile in streptozotocin induced diabetic rats
by: Deniz Uluışık, et al.

Novel Lipid-Based Formulation to Enhance Coenzyme Q10 Bioavailability: Preclinical Assessment and Phase 1 Pharmacokinetic Trial
by: Andrea Fratter, et al.
Published: (2025-03-01)

Associations between dietary coenzyme Q10 intake and lipid profiles in adults: a national cross-sectional study
by: Mingzhu Zhao, et al.
Published: (2024-11-01)

Coenzyme Q deficiency causes impairment of the sulfide oxidation pathway
by: Marcello Ziosi, et al.
Published: (2016-11-01)

ADVANCED USE OF COENZYME Q10 IN PATIENTS WITH CARDIOVASCULAR DISEASES
by: A. I. Martynov, et al.
Published: (2013-03-01)

Comparative Potential of Zinc Sulfate, L-Carnitine, Lycopene, and Coenzyme Q10 on Cadmium-Induced Male Infertility
by: Ayesha Iftikhar, et al.
Published: (2022-01-01)

Molecular pharmacology of coenzyme Q10 in the context of treatment of hyperlipidemic conditions
by: O. A. Gromova, et al.
Published: (2023-07-01)

The effects of coenzyme q10 on testes of rats with diabetes induced by streptozotocin
by: Tuğba Özaydın, et al.
Published: (2021-12-01)

THE IMPACT OF CARDIOVASCULAR AND BRONCHOPULMONARY DISEASES ON COENZYME Q10 PLASMA CONCENTRATION
by: V. I. Zozina, et al.
Published: (2019-03-01)

COENZYME Q<sub>10</sub> IN THE COMPLEX TREATMENT OF ARTERIAL HYPERTENSION
by: Yu. P. Pereponov
Published: (2011-10-01)

Diabetes Risks of Statin Therapy—Coenzyme Q10 May Help
by: Xiaorong Han, et al.
Published: (2025-02-01)

Acute Hypoglycemia Induces Painful Neuropathy and the Treatment of Coenzyme Q10
by: Yan Ping Zhang, et al.
Published: (2016-01-01)

Coenzyme Q10 Supplementation Effects on In Vitro Oocyte Maturation, Lipid Peroxidation, and Embryonic Development in Prepubertal and Aging Thai–Holstein Cows
by: Ruthaiporn Ratchamak, et al.
Published: (2024-12-01)

Statement of Retraction: The effects of coenzyme Q10 supplementation on gene expression related to insulin, lipid and inflammation in patients with polycystic ovary syndrome
Published: (2024-12-01)

Evaluating the Role of Coenzyme Q10 in Migraine Therapy—A Narrative Review
by: Anna Fajkiel-Madajczyk, et al.
Published: (2025-03-01)

Coenzyme Q10 Levels Are Decreased in the Cerebellum of Multiple-System Atrophy Patients.
by: Lucia V Schottlaender, et al.
Published: (2016-01-01)

Evaluation of Coenzyme Q10 Redox Status as a Biomarker of Oxidative Stress
by: O. A. Goroshko, et al.
Published: (2019-09-01)

THE MODERN METHODS OF ANALYSIS OF OXIDIZED AND REDUCED FORMS OF COENZYME Q₁₀ IN BIOMATERIAL (REVIEW)
by: V. I. Zozina, et al.
Published: (2019-01-01)

Coenzyme Q10 and embryonic development: a potential role in reproductive medicine
by: A. U. Khamadyanova, et al.
Published: (2024-11-01)

Effect of coenzyme Q10 on tibial fracture resistance in nicotine-exposed rats.
by: Ruan Henrique Delmonica Barra, et al.
Published: (2025-01-01)

Effects of coenzyme q10 supplementation on metabolic and reproductive outcomes in obese rats
by: Gisela Belén Sarrible, et al.
Published: (2025-02-01)

What are biopharmaceuticals?
by: Abhay H. Pande, et al.
Published: (2025-01-01)

Effects of Coenzyme Q10 on Markers of Inflammation: A Systematic Review and Meta-Analysis.
by: Junya Zhai, et al.
Published: (2017-01-01)

Coenzyme Q10 and alpha-lipoic acid: A hirata's connection to severe hypoglycemia?
by: Sulekha Mahendran, et al.
Published: (2020-01-01)

A study on coenzyme q10, experimentally induced diabetes and liver enzymes in rats
by: Ercan Keskin, et al.

Early form of mitochondrial epileptic encephalopathy due to primary deficiency of coenzyme Q10
by: T. V. Melashenko, et al.
Published: (2024-04-01)

Miso Soup Consumption Enhances the Bioavailability of the Reduced Form of Supplemental Coenzyme Q10
by: Michiyo Takahashi, et al.
Published: (2020-01-01)

The Role of Coenzyme Q10 Supplementation as a Potential Adjunct in the Treatment of Autoimmune Diseases
by: Martyna Bukała, et al.
Published: (2025-06-01)

Coenzyme Q10 Enhances Resilience of Mitochondrial-like Membranes Against Amyloidogenic Peptides
by: Raina Marie Seychell, et al.
Published: (2025-05-01)

Prenatal and progressive coenzyme Q10 administration to mitigate muscle dysfunction in mitochondrial disease
by: Juan Diego Hernández‐Camacho, et al.
Published: (2024-12-01)

Citicoline and Coenzyme Q10: Therapeutic Agents for Glial Activation Reduction in Ocular Hypertension
by: José A. Matamoros, et al.
Published: (2025-05-01)

The Role of Coenzyme Q10 in Modern Medicine: Insights into Energy Metabolism and Antioxidant Therapy
by: Mateusz Górski, et al.
Published: (2025-01-01)

Development of Solid Self-Nanoemulsifying Drug Delivery System of Rhein to Improve Biopharmaceutical Performance: Physiochemical Characterization, and Pharmacokinetic Evaluation
by: More SM, et al.
Published: (2025-01-01)

Pathogenetic rationale for using an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and an antioxidant coenzyme Q<sub>10</sub> in the treatment and prevention of cardiovascular disease
by: S. G. Dzugkoev, et al.
Published: (2021-10-01)

DOWNSTREAM PROCESS OF BIOPHARMACEUTICALS
by: D. A. Gusarov
Published: (2019-01-01)

VIRAL BIOSAFETY OF BIOPHARMACEUTICALS
by: D. A. Gusarov
Published: (2019-01-01)

Enhanced solubility and bioavailability of coenzyme Q10 via co-amorphous system using stevioside
by: Yingting Luo, et al.
Published: (2025-06-01)

Protective role of coenzyme Q10 against trihexyphenidyl-induced pulmonary toxicity in Wistar rats
by: Joseph Gbenga Omole, et al.
Published: (2025-05-01)